PAMU
KERX

Pictet Asset Management (UK)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Pictet Asset Management (UK)’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-274,900
Closed -$2.93M – 906
2015
Q1 		$2.93M Sell
274,900
-176,665
-39% -$2.27M 0.01% 689
2014
Q4 		$6.39M Buy
451,565
+243,765
+117% +$3.78M 0.03% 514
2014
Q3 		$2.86M Sell
207,800
-10,200
-5% -$156K 0.01% 676
2014
Q2 		$3.35M Buy
218,000
+33,100
+18% +$469K 0.02% 646
2014
Q1 		$3.15M Buy
184,900
+46,400
+34% +$700K 0.02% 650
2013
Q4 		$1.79M Buy
+138,500
New +$1.65M 0.01% 750

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Pictet Asset Management (UK)'s KERX Position: Q2 2015 in Review

Pictet Asset Management (UK) sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2015, closing a stake of 274,900 shares — an estimated $2.93M sold.

Pictet Asset Management (UK) first reported a position in KERX in Q4 2013 and held it in 6 quarters. The position peaked at $6.39M in Q4 2014. 153 funds tracked by Wall St. Rank hold KERX as of Q2 2015.

  • Pictet Asset Management (UK) reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 274,900 Keryx Biopharmaceuticals Inc shares in Q2 2015, an estimated $2.93M.
  • Pictet Asset Management (UK) first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Pictet Asset Management (UK)'s Keryx Biopharmaceuticals Inc position peaked at $6.39M in Q4 2014.
  • 153 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2015, filed 13 Aug 2015.